Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement
Status:
Withdrawn
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Assess impact of increasing dose of dexmedetomidine on total daily dose of fentanyl and
propofol while maintaining sedation in a mechanically ventilated patient in a general medical
intensive care unit.
Phase:
Phase 4
Details
Lead Sponsor:
Avera McKennan Hospital & University Health Center
Treatments:
Analgesics Dexmedetomidine Hypnotics and Sedatives